VPTDF (VentriPoint Diagnostics) Long-Term Debt: $0.03 Mil (As of Dec. 2025)


VPTDF VentriPoint Diagnostics Ltd VPTDF
10 GF Score
Price $0.08
! 4 Warning Signs
View Full Analysis

What is VentriPoint Diagnostics Long-Term Debt?

VentriPoint Diagnostics VPTDF -4.66% 10 Long-Term Debt is $0.03 Mil as of Dec. 2025. GuruFocus rates VPTDF with a GF Score™ of 10/100. The stock has 4 warning signs investors should review.

VentriPoint Diagnostics's Long-Term Debt for the quarter that ended in Dec. 2025 was $0.03 Mil.

VentriPoint Diagnostics's quarterly Long-Term Debt declined from Jun. 2025 ($0.04 Mil) to Sep. 2025 ($0.03 Mil) and declined from Sep. 2025 ($0.03 Mil) to Dec. 2025 ($0.03 Mil).

VentriPoint Diagnostics's annual Long-Term Debt declined from Dec. 2023 ($0.06 Mil) to Dec. 2024 ($0.04 Mil) and declined from Dec. 2024 ($0.04 Mil) to Dec. 2025 ($0.03 Mil).

VentriPoint Diagnostics  (OTCPK:VPTDF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

VentriPoint Diagnostics Long-Term Debt Related Terms

VentriPoint Diagnostics Long-Term Debt Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VentriPoint Diagnostics Long-Term Debt Chart

VentriPoint Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.07 0.06 0.04 0.03

VentriPoint Diagnostics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.04 0.03 0.03
VPTDF
10GF Score
VentriPoint Diagnostics Ltd VPTDF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.03 Mil mean?
VentriPoint Diagnostics (VPTDF) has a Long-Term Debt of $0.03 Mil as of Dec. 2025.
Is VentriPoint Diagnostics' Long-Term Debt too high?
VentriPoint Diagnostics' current Long-Term Debt is $0.03 Mil. Overall, VentriPoint Diagnostics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does VentriPoint Diagnostics' Long-Term Debt compare to ABT and SYK?
VentriPoint Diagnostics' Long-Term Debt of $0.03 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. VentriPoint Diagnostics's current Long-Term Debt is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VentriPoint Diagnostics stock overvalued right now?
VentriPoint Diagnostics (VPTDF) has a current Long-Term Debt of $0.03 Mil. The current Long-Term Debt is $0.03 Mil. VentriPoint Diagnostics' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For VentriPoint Diagnostics (VPTDF), the current Long-Term Debt is $0.03 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VentriPoint Diagnostics Business Description

Other Exchanges VPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
10GF Score

Get the complete analysis for VPTDF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price